Group items tagged

This provides a comprehensive analysis of the European therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

Reports & Insights has freshly issued a new report titled "Cannabis Market: Opportunity Analysis and Future Assessment 2022-2030" which speaks about the market size, market potential and comprehensive understanding of the statistics concerned with the development of the respective market. The market analysts estimate that the Cannabis Market size will elevate from 28.1 Bn in 2022 to 197.5 Bn by the year 2030, at an estimated CAGR of 27.6%. The base year considered for the study is 2020, and the market size is projected from 2022 to 2030. The cannabis market is estimated to reach at a value of US$ 28.1 Bn by the end of 2022 and expected to reach at a value of US$ 197.5 Bn by 2030 with a significant CAGR of 27.6%. Request a Sample Copy of this Report @: https://reportsandinsights.com/sample-request/8265 Cannabis Introduction Cannabis sativa L. (Cannabaceae) is one of the earliest medicinal plants utilized by humans. Basically, Cannabis is the preferable identification name of the plant Cannabis indica, Cannabis sativa, and of minor significance, Cannabis ruderalis. For thousands of years, the plant has served its utility for mankind for oil and fiber production, and simply as a supplement for different food items. Cannabis is the world's most ordinarily cultivated, smuggled, and used as unauthorized and illegal drug, and in addition to that, as the encouragement for legalization of cultivation of cannabis at home and abroad is surging, cannabis or marijuana is gaining significant attention from manufacturers, investors, and researchers across the world. Moreover, cannabis is considered to contain a variety of medicinally essential compounds such as, terpenoids, cannabinoids, alkaloids, flavonoids, and others, which further escalates its applications in medicinal uses in the healthcare sector. Cannabis, which was once considered an unauthorized and illegal substance is believed a restricted and governed drug within several government guidelines in presen